New approaches aim to extend treatment durability and improve long-term vision outcomes in wet AMD. Scientific American Custom Media recently sat down with Dr. Nadia Waheed, Ocular Therapeutix’s chief medical officer, to discuss the real-world burden behind the standard of care and how emerging approaches, including sustained-delivery therapies under investigation, aim to reduce it. This podcast was produced for Ocular Therapeutix by Scientific American Custom Media, a division separate from the magazine’s board of editors. Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Science Quickly
Why we’re still obsessed with vampires
Why science is on the ballot in the midterms
Finding Nutrition Truth in a World of Myths [Sponsored]
Cartwheeling snakes, vocal vultures and a mysterious Martian moon
Get summaries like this every morning.
Free AI-powered recaps of Science Quickly and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.